drugset / Trial / NCT07088588
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN608 as monotherapy in adult patients with advanced solid tumors
Timeline
- Start
- 2025-07-31
- Primary completion
- 2028-07-31
- Completion
- 2028-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYN608 | Unknown | — | Oral |